Figure 2From: Administration of fibrinogen concentrate for refractory bleeding in massively transfused, non-trauma patients with coagulopathy: a retrospective study with comparator group Patients (N) included into a massive transfusion protocol. Comparisons were performed between: (1) patients receiving (FBNc group) or not (comparator group) fibrinogen concentrate (FBNc); (2) patients receiving (FBNc group) or not (comparator group) FBNc and successfully pair-matched by SOFA, age and diagnosis; and (3) patients achieving or not a fibrinogen level ≥2 g/lBack to article page